Showing results (51-60 of 94) with videos related to
Sort By:
Pageof 10
Journal of Neuroendocrinology|August 9, 2025
Controversies in NEN: An ENETS position statement on the treatment of patients with Grade 3 well-differentiated neuroendocrine tumours of the gastro-enteropancreatic tractMairéad G McNamara, Halfdan Sorbye, Nehara Begum, et al.The Lancet. Gastroenterology & Hepatology|March 11, 2019
Reduced-dose combination chemotherapy (S-1 plus oxaliplatin) versus full-dose monotherapy (S-1) in older vulnerable patients with metastatic colorectal cancer (NORDIC9): a randomised, open-label phase 2 trialStine Braendegaard Winther, Gabor Liposits, Halla Skuladottir, et al.Journal of Geriatric Oncology|December 9, 2022
Prognostic value of baseline functional status measures and geriatric screening in vulnerable older patients with metastatic colorectal cancer receiving palliative chemotherapy - The randomized NORDIC9-studyGabor Liposits, Jesper Ryg, Halla Skuladottir, et al.Acta Oncologica (Stockholm, Sweden)|August 21, 2014
Nordic guidelines 2014 for diagnosis and treatment of gastroenteropancreatic neuroendocrine neoplasmsEva Tiensuu Janson, Halfdan Sorbye, Staffan Welin, et al.Acta Oncologica (Stockholm, Sweden)|May 17, 2021
Nordic guidelines 2021 for diagnosis and treatment of gastroenteropancreatic neuroendocrine neoplasmsEva Tiensuu Janson, Ulrich Knigge, Gitte Dam, et al.European Journal of Cancer (Oxford, England : 1990)|September 7, 2015
Prognostic impact of immune response in resectable colorectal liver metastases treated by surgery alone or surgery with perioperative FOLFOX in the randomised EORTC study 40983Erik Tanis, Catherine Julié, Jean-Francois Emile, et al.JCO Precision Oncology|February 8, 2023
Mutation Spectrum in Liquid Versus Solid Biopsies From Patients With Advanced Gastroenteropancreatic Neuroendocrine CarcinomaStian Knappskog, Tobias Grob, Andreas Venizelos, et al.Gut|March 11, 2021
Treatment of advanced gastroenteropancreatic neuroendocrine neoplasia, are we on the way to personalised medicine?Anja Rinke, Christoph J Auernhammer, Lisa Bodei, et al.British Journal of Cancer|April 12, 2017
Cetuximab in treatment of metastatic colorectal cancer: final survival analyses and extended RAS data from the NORDIC-VII studyTormod Kyrre Guren, Maria Thomsen, Elin H Kure, et al.Plos Genetics|July 30, 2016
Intra-patient Inter-metastatic Genetic Heterogeneity in Colorectal Cancer as a Key Determinant of Survival after Curative Liver ResectionAnita Sveen, Inger Marie Løes, Sharmini Alagaratnam, et al.Pageof 10